Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC
Nivolumab plus ipilimumab improves on chemo in previously untreated MSI-H/dMMR mCRC
T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Vitamin D in patients with low tumour-burden indolent non-Hodgkin lymphoma treated with rituximab therapy
Lived experiences of survival following cancer treatments
The genomics of cancer in Africa
DNA methylation profile of prostate cancer aggressiveness in Ghana
SABCS 2023: Highlights
Preoperative endocrine therapy in premenopausal women leads to sparing chemotherapy in additional patients
Ide-cell enhances health-related quality of life for refractory multiple myeloma
Synthetic biology and precision medicine in blood and gynaecological cancers
Adding nivolumab to R-GemOx shows enhanced efficacy in treating R/R large B-cell lymphoma